Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 25.
doi: 10.1037/neu0001036. Online ahead of print.

Using the Modified Taylor Complex Figure-Recognition Trial (MTCF-RT) to differentiate amnestic patients with Alzheimer's disease from patients with memory deficits due to Parkinson's disease or subcortical ischemic vascular dementia

Affiliations

Using the Modified Taylor Complex Figure-Recognition Trial (MTCF-RT) to differentiate amnestic patients with Alzheimer's disease from patients with memory deficits due to Parkinson's disease or subcortical ischemic vascular dementia

Edoardo Barvas et al. Neuropsychology. .

Abstract

Objective: The Modified Taylor Complex Figure-Recognition Trial (MTCF-RT) is a visual recognition memory measure that consists of a recognition trial to be administered after the copy and the delayed reproduction of the Modified Taylor Complex Figure Test. The aim of this study was to validate the MTCF-RT in differentiating amnestic patients with Alzheimer's disease (AD) from patients with memory deficits due to Parkinson's disease (PD) or subcortical ischemic vascular dementia (SIVD).

Method: The MTCF-RT was administered to 25 amnestic patients with AD and 25 patients with memory deficits due to SIVD (n = 18) or PD (n = 7). Additionally, the recognition trial was administered to 40 neurologically unimpaired individuals. All patients were tested on a brief neuropsychological battery, and their magnetic resonance scans were assessed for medial temporal lobe atrophy.

Results: MTCF-RT performance was significantly lower in the group of amnestic patients with AD than in the group of amnestic patients with non-AD disorders, whereas healthy subjects performed significantly better than the two experimental groups. The MTCF-RT allowed identifying amnestic patients with AD with 92% sensitivity and 96% specificity using a cutoff of ≤7.358, showing a higher discriminant power with respect to other long-term memory measures. Finally, MTCF-RT scores showed a high negative correlation with medial temporal lobe atrophy and a positive correlation with other long-term memory measures.

Conclusions: MTCF-RT could be a useful tool, as part of a larger neuropsychological battery, for discriminating patients with AD from those with memory deficits due to PD or SIVD. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

PubMed Disclaimer